Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 250,000 shares at $51.98 ($12.9M) on 2020-10-01, disclosed to the SEC on 2020-10-05.
Open-market sale of $12.9M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.52 | 101,114 | $5.2M | 40.4% |
| 2 | $51.52 | 101,114 | $5.2M | 40.4% |
| 3 | $51.98 | 23,886 | $1.2M | 9.6% |
| 4 | $51.98 | 23,886 | $1.2M | 9.6% |
| Total | $51.61 avg | 250,000 | $12.9M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |